LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

NCT03244020 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

2868

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Soft Tissue Sarcoma
Bone Sarcoma
Bone Metastases
Venous Thromboembolism
Hematoma
Anticoagulant-induced Bleeding

Interventions

DRUG: Aspirin 325mg
DRUG: Enoxaparin 40Mg/0.4mL Prefilled Syringe

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]